About Dr. Jiang Jingwen
Dr. Jiang Jingwen (蒋景文) is a Professor, Doctoral Supervisor, and one of China's leading neurologists specializing in neuromuscular disease, based at the Department of Neurology, Huashan Hospital, Fudan University. With extensive clinical and research expertise in the diagnosis and management of peripheral neuropathies, myopathies, motor neuron diseases, neuromuscular junction disorders, and hereditary neuromuscular conditions, Dr. Jiang is recognized as a senior authority in neuromuscular medicine at one of China's most distinguished and internationally recognized neurology departments.
Neuromuscular diseases encompass a broad and diagnostically challenging spectrum of conditions affecting the motor neuron, peripheral nerve, neuromuscular junction, and muscle — including amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth disease (CMT) and other hereditary neuropathies, Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Lambert-Eaton myasthenic syndrome, Duchenne and Becker muscular dystrophy, limb-girdle muscular dystrophies, facioscapulohumeral muscular dystrophy (FSHD), inclusion body myositis, inflammatory myopathies (dermatomyositis, polymyositis, anti-synthetase syndrome), and metabolic myopathies including Pompe disease. The precise diagnosis of these conditions — which frequently requires the integration of clinical assessment, nerve conduction studies and electromyography (EMG), muscle and nerve biopsy pathology, genetic testing, and specialized laboratory investigations — is essential for appropriate management and genetic counseling, and requires a level of specialist expertise that is available at only a small number of dedicated neuromuscular disease centers.
Huashan Hospital's Department of Neurology — one of China's foremost neurology programs — provides the full range of diagnostic and therapeutic capabilities for neuromuscular disease, including a dedicated neuromuscular disease clinic, a high-volume EMG laboratory, muscle and nerve biopsy pathology services, comprehensive genetic testing for hereditary neuromuscular conditions, and access to disease-modifying therapies including enzyme replacement therapy for Pompe disease, nusinersen and risdiplam for spinal muscular atrophy (SMA), and immunotherapy for inflammatory neuropathies and myopathies.
Hospital Affiliation: Department of Neurology, Huashan Hospital
Huashan Hospital (华山医院), affiliated with Fudan University, is one of China's most prestigious and internationally recognized academic medical centers, with particular national and international recognition in neurology, neurosurgery, infectious disease, dermatology, and hand surgery. Its Department of Neurology is consistently ranked among the top neurology departments in China, with a comprehensive clinical and research program spanning stroke, epilepsy, movement disorders, dementia, multiple sclerosis, neuromuscular disease, headache, and neuro-oncology. The department's neuromuscular disease program is one of the most active in China, with a dedicated neuromuscular clinic, a high-volume EMG laboratory performing thousands of nerve conduction studies and EMG examinations annually, and a muscle and nerve biopsy pathology service with immunohistochemistry, electron microscopy, and molecular pathology capabilities.
The department maintains active research collaborations with neuromuscular disease centers across China and internationally, and participates in national and international clinical trials of novel therapies for ALS, SMA, muscular dystrophies, and inflammatory neuropathies and myopathies. Its genetic testing program provides comprehensive panel-based and whole-exome sequencing for hereditary neuromuscular conditions, enabling precise molecular diagnosis that guides management and genetic counseling.
Clinical Specialties: What Dr. Jiang Jingwen Treats
- Peripheral neuropathies — comprehensive electrodiagnostic assessment (nerve conduction studies and EMG) for peripheral neuropathy characterization; diagnosis and management of CIDP including intravenous immunoglobulin (IVIg), plasma exchange, and corticosteroids; GBS acute management and IVIg/plasma exchange therapy; multifocal motor neuropathy (MMN) diagnosis and IVIg therapy; vasculitic neuropathy diagnosis and immunosuppressive management; diabetic peripheral neuropathy assessment and management; hereditary neuropathy diagnosis including CMT genetic panel testing
- Motor neuron disease — ALS diagnosis using El Escorial and Awaji criteria; riluzole and edaravone therapy; multidisciplinary ALS care coordination including respiratory support, nutritional support, communication aids, and palliative care; spinal muscular atrophy (SMA) diagnosis and disease-modifying therapy with nusinersen (intrathecal) and risdiplam (oral); Kennedy disease (SBMA) diagnosis and management
- Neuromuscular junction disorders — myasthenia gravis diagnosis including acetylcholine receptor antibody, MuSK antibody, and LRP4 antibody testing; repetitive nerve stimulation and single-fiber EMG; pyridostigmine therapy; immunosuppression with corticosteroids, azathioprine, mycophenolate mofetil, and tacrolimus; IVIg and plasma exchange for myasthenic crisis; thymoma assessment and thymectomy coordination; eculizumab and efgartigimod for refractory generalized MG; Lambert-Eaton myasthenic syndrome (LEMS) diagnosis and management
- Muscular dystrophies — Duchenne and Becker muscular dystrophy diagnosis including dystrophin gene deletion/duplication analysis and muscle biopsy; corticosteroid therapy for DMD; cardiac and respiratory monitoring and management; limb-girdle muscular dystrophy (LGMD) genetic panel diagnosis; facioscapulohumeral muscular dystrophy (FSHD) diagnosis; Emery-Dreifuss muscular dystrophy diagnosis and cardiac monitoring; myotonic dystrophy type 1 and 2 diagnosis and multisystem management
- Inflammatory myopathies — diagnosis of dermatomyositis, polymyositis, immune-mediated necrotizing myopathy (IMNM), and anti-synthetase syndrome using myositis-specific antibody panel, muscle biopsy, and MRI; corticosteroid induction and immunosuppressive maintenance therapy; IVIg for refractory inflammatory myopathy; coordination with rheumatology for overlap syndrome management; interstitial lung disease screening and management in anti-synthetase syndrome; inclusion body myositis diagnosis and management
- Metabolic and mitochondrial myopathies — Pompe disease (glycogen storage disease type II) diagnosis including acid alpha-glucosidase (GAA) enzyme activity assay and GAA gene testing; enzyme replacement therapy (alglucosidase alfa, avalglucosidase alfa) for Pompe disease; mitochondrial myopathy diagnosis including muscle biopsy with modified Gomori trichrome stain, respiratory chain enzyme assay, and mitochondrial DNA analysis; McArdle disease and other glycogen storage myopathies
- Hereditary neuromuscular disease genetic counseling — comprehensive genetic panel testing and whole-exome sequencing for hereditary neuropathies, muscular dystrophies, and other hereditary neuromuscular conditions; variant interpretation and genetic counseling coordination; family cascade testing; prenatal diagnosis coordination for families with known pathogenic variants
Why International Patients Choose Dr. Jiang Jingwen and Huashan Hospital
International patients seek neuromuscular disease consultation with Dr. Jiang Jingwen and Huashan Hospital for reasons that reflect both the diagnostic complexity of neuromuscular conditions and the comprehensive diagnostic and therapeutic capabilities available at the department.
For patients with undiagnosed neuromuscular weakness — a common and diagnostically challenging presentation that may reflect peripheral neuropathy, myopathy, motor neuron disease, or neuromuscular junction disorder — Dr. Jiang's systematic approach to electrodiagnostic assessment, muscle and nerve biopsy, and genetic testing provides the precise diagnosis that is the foundation of appropriate management and genetic counseling. The availability of comprehensive myositis-specific antibody panels, hereditary neuromuscular genetic panels, and whole-exome sequencing at Huashan Hospital enables a level of diagnostic precision that is difficult to access outside major academic neuromuscular disease centers.
For patients with established diagnoses of myasthenia gravis, CIDP, inflammatory myopathy, or SMA who are not achieving optimal disease control with current therapy, Dr. Jiang's expertise in the full range of immunotherapy options — including newer agents such as efgartigimod for MG and nusinersen/risdiplam for SMA — provides access to treatment optimization that may not be available at the patient's home institution. The cost of neuromuscular disease consultation, electrodiagnostic testing, and immunotherapy at Huashan Hospital is substantially below that of equivalent care in Western healthcare systems, and access to specialist consultation can typically be arranged within days through CMCS.
What to Expect at Your Consultation
Consultations with Dr. Jiang Jingwen at Huashan Hospital arranged through CMCS begin with a comprehensive review of all prior neurological records — including nerve conduction studies and EMG reports, muscle and nerve biopsy pathology, genetic testing results, myositis antibody panel results, relevant laboratory investigations (CK, LDH, aldolase, thyroid function, autoimmune screen), prior treatment records, and the patient's neuromuscular symptom history including onset, progression, distribution of weakness, and functional impact. CMCS will arrange certified translation of all medical records and investigation results in advance of the consultation. Dr. Jiang will assess the neuromuscular syndrome, evaluate the diagnostic workup and identify any gaps, outline the recommended diagnostic and therapeutic strategy, and coordinate genetic counseling where indicated. A written English-language consultation summary is provided after every appointment, and CMCS will facilitate direct communication between Dr. Jiang's team and the patient's home neurologist for continuity of care planning.
Book a Consultation Through CMCS
China Medical Concierge Shanghai (CMCS) provides comprehensive end-to-end support for international patients seeking neuromuscular disease consultation with Dr. Jiang Jingwen at Huashan Hospital. Our services include priority consultation scheduling, certified medical record and EMG report translation, coordination of nerve conduction studies, muscle biopsy, and genetic testing, on-site interpretation throughout the consultation, and written English-language reporting of all findings and recommendations. CMCS will also facilitate direct communication between Dr. Jiang's team and the patient's home neurologist to ensure seamless continuity of care.
📧 contract@medicalsh.com | 💬 WeChat: gezhanglao | 🌐 medicalsh.com
0 comments